U.S. market Closed. Opens in 3 hours 8 minutes

IMCR | Immunocore Holdings plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue249.43M143.74M26.52M30.11M25.67M23.65M
Cost of Revenue1.04M454.00K73.23M74.81M99.99MN/A
Gross Profit248.39M143.28M-46.71M-44.70M-74.32M23.65M
Operating Expenses308.04M182.89M161.68M119.40M144.17M117.73M
Selling, General & Admin144.50M93.72M88.40M45.74M44.18M34.16M
Research & Development163.54M89.17M73.23M74.81M99.99M83.58M
Other Operating Expenses-897.00K-3.00K57.00K-1.15M185.00K5.60M
Operating Income-59.65M-39.61M-135.16M-86.19M-118.32M-93.45M
Other Expenses / Income-14.07M-4.54M-5.77M-1.17M-7.87M5.92M
Before Tax Income-60.89M-44.15M-140.93M-87.36M-126.19M-88.18M
Income Tax Expenses-5.60M-2.92M-9.40M-13.27M-22.26M-16.55M
Net Income-55.29M-41.22M-131.52M-74.09M-103.93M-71.63M
Interest Expenses5.15M7.69M5.81M3.11M3.80M842.00K
Basic Shares Outstanding48.89M45.71M42.49M31.78M27.31M27.31B
Diluted Shares Outstanding48.89M45.71M43.86M31.78M27.31M27.31B
EBITDA-38.47M-36.45M-135.12M-75.45M-107.71M-80.95M
EBITDA Margin-15.42%-25.36%-509.48%-250.54%-419.63%-342.21%
EBIT-55.74M-36.45M-135.12M-84.25M-122.39M-87.34M
EBIT Margin-22.35%-25.36%-509.48%-279.77%-476.81%-369.22%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙